Impact of Current Bone Medications on Bone Density and Expected Change Values
Includes a Live Web Event on 04/25/2026 at 11:00 AM (EDT)
Impact of Current Bone Medications on Bone Density and Expected Change Values
Saturday, April 25, 2026, 11:00am - 12:00pm Eastern Time (NY/USA)
Description and Objectives
This educational session will provide a practical overview of current pharmacologic options for the prevention and treatment of osteoporosis. Participants will review commonly used bone medications and gain a clear understanding of how these therapies differ in their mechanisms of action on bone remodeling. The program will also address expected changes in bone mineral density associated with various treatments, including realistic timelines for achieving clinically meaningful improvement, to support informed decision-making and patient counseling.
After attending this lecture, participants will be able to:
- List current bone medications used for osteoporosis prevention and treatment.
- Differentiate the mechanisms of action of these medications on bone.
- Describe expected bone density changes and the time intervals required to observe clinically meaningful improvement.
Handouts
All speakers were asked to provide handouts/lecture slides for registered attendees. Those that were provided for this session will be uploaded to the handouts tab and can be accessed/downloaded from that tab.
E. Michael Lewiecki, MD, FACP, FACE, CCD
Director
New Mexico Clinical Research & Osteoporosis Center, Inc.
E. Michael Lewiecki, MD, CCD, FACP, FACE, FASBMR, is Director of New Mexico Clinical Research & Osteoporosis Center and Director of Bone Health ECHO at University of New Mexico Health Sciences Center in Albuquerque, NM. His is a consultant in osteoporosis and metabolic bone disease, supervisor and interpreter of bone density studies, and an educator with a special interest in the evaluation and treatment of osteoporosis and metabolic bone diseases. He has been principal investigator for many osteoporosis clinical trials and is author of over 300 publications in peer-reviewed medical journals, as well as books, book chapters, and online publications on osteoporosis. Dr. Lewiecki is past-president of the International Society for Clinical Densitometry (ISCD) and current president of the Osteoporosis Foundation of New Mexico (OFNM). He is an editor for Osteoporosis International, and is on the editorial boards of the Journal of Bone and Mineral Research and the Journal of Clinical Densitometry. He has received national and international awards that include the 2021 “Dr. John P. Bilezikian ISCD Global Leadership Award” and the 2021 “Lawrence G. Raisz Memorial Lecture Award” with the Bone Health & Osteoporosis Foundation. Dr. Lewiecki is the program director of the annual Santa Fe Bone Symposium, the flagship activity of the OFNM.